Project Grant R21AR082123
Award Date
9/20/24
Completion Date
8/31/26
Dollars Obligated
$1.2M
Similar Awards
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $196,460 Project Grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to the University of Pittsburgh. The purpose of this 30-month grant, with a start date of January 30, 2025, is to develop and utilize a novel microphysiological system to study neuro-immune interactions that contribute to osteoarthritis (OA) pain. The research aims to: 1) understand how inflammatory molecules from...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $644,152 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to the University of North Carolina at Chapel Hill. The grant, effective from January 20, 2025 through December 31, 2029, aims to identify the mechanistic pathway linking aberrant limb-level loading during walking to the development and progression of knee osteoarthritis. The research will use in...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $174,689 to The General Hospital Corporation (doing business as Massachusetts General Hospital) for a 5-year research project. The project aims to investigate the relationship between structural damage biomarkers detected through MRI and CT imaging, and different pain phenotypes...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), aims to investigate the therapeutic role of the NFAT1 transcription factor in the treatment of osteoarthritis (OA). The $350,000 award, spanning from August 1, 2024 to July 31, 2029, will support two specific aims: 1) Investigating the therapeutic potential of AAV-NFAT1 (adeno-associated virus delivered NFAT1 transgene) in knee OA...
This federal Project Grant award, provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will define and validate guidelines for the interpretation of commonly used patient-reported outcome measures (PROMs) for pain and physical function among patients with advanced knee osteoarthritis. The total funding amount is $711,161.00, with an award date of July 16, 2024 and an...
The University of Arizona was awarded a $348,680 Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The goal of this 2-year research project is to develop computational tools to accurately predict and interpret different knee pain spatial patterns in patients with osteoarthritis based on magnetic resonance imaging (MRI) data. The project aims to adapt a deep...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $299,820 to Trustees of Boston University to conduct a digital feasibility study on a telehealth mindful exercise intervention for individuals with knee osteoarthritis. The study aims to determine the feasibility of the telehealth mindful exercise program, examine the feasibility of...
This federal Project Grant award, valued at $219,605.00 and provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to characterize the role of the mechanosensitive ion channel PIEZO1 in driving pathological synovial fibrosis and inflammation in post-traumatic osteoarthritis (PTOA). The key products and services to be delivered through this award include: 1)...
The federal Project Grant award R01AR084472, with total funding of $1,657,392.00, was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The purpose of the grant is to repurpose FDA-approved drugs for the treatment of osteoarthritis (OA) using high-throughput screening in microphysiological models. The grant recipient, the University of Pittsburgh, will utilize...
This $359,207 federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) aims to develop optical redox imaging (ORI) medical instruments to guide surgical and therapeutic approaches for early cartilage damage and osteoarthritis. The key products and services to be delivered include: Developing a stress test to diagnose cartilage disease based on changes in...